We are live on ! Find out more
SER icon

Serina Therapeutics
SER

59 hedge funds and large institutions have $24.8M invested in Serina Therapeutics in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

32% more capital invested

Capital invested by funds: $18.7M → $24.8M (+$6.01M)

13% more funds holding

Funds holding: 52 → 59 (+7)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less ownership

Funds ownership: 0.49% → 0.48% (-0%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

Holders
59
Holders Change
+7
Holders Change %
+13.46%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
13
Reduced
16
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCM
Price Capital Management
Louisiana
+$182K
2
SPC
Sigma Planning Corp
Michigan
+$142K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$134K
4
ECM
ExodusPoint Capital Management
New York
+$76.8K
5
DWM
Destination Wealth Management
California
+$74.4K

Top Sellers

Rank Fund Capital Flow
1
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$429K
2
State Street
State Street
Massachusetts
-$155K
3
DC
Defender Capital
North Carolina
-$120K
4
BlackRock
BlackRock
New York
-$82.3K
5
Jane Street
Jane Street
New York
-$70K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$44K -$7.31K -50 -14%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$28K – – –
Morgan Stanley
28
Morgan Stanley
New York
$27K -$50K -342 -65%
JP Morgan Chase
29
JP Morgan Chase
New York
$26K +$15.8K +108 +146%
TRCT
30
Tower Research Capital (TRC)
New York
$26K +$18K +123 +232%
Bank of America
31
Bank of America
North Carolina
$24K -$7.17K -49 -22%
AIG
32
American International Group
New York
$24K -$146 -1 -0.6%
Barclays
33
Barclays
United Kingdom
$19K +$19.4K +133 +1,900%
UBS Group
34
UBS Group
Switzerland
$14K -$2.92K -20 -17%
Citigroup
35
Citigroup
New York
$11K -$2.78K -19 -20%
BDS
36
Banco de Sabadell
Florida
$8K – – –
CHP
37
Cable Hill Partners
Oregon
$8K +$8.34K +57 New
Legal & General Group
38
Legal & General Group
United Kingdom
$5K – – –
Group One Trading
39
Group One Trading
Illinois
$5K +$4.39K +30 +1,500%
RAM
40
Riggs Asset Management
Pennsylvania
$4K – – –
RE
41
RBC Europe
United Kingdom
$2.31K – – –
MAM
42
Meeder Asset Management
Ohio
$2K -$439 -3 -19%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$2K -$146 -1 -8%
AIP
44
Ameritas Investment Partners
Nebraska
$2K – – –
Canada Life
45
Canada Life
Manitoba, Canada
$2K – – –
FANJ
46
Financial Architects (New Jersey)
New Jersey
$2K – – –
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$2K +$1.9K +13 New
RFA
48
Reilly Financial Advisors
California
$1K – – –
AG
49
Advisor Group
Arizona
$1K +$292 +2 +22%
AIC
50
Ameritas Investment Company
Nebraska
$1K +$1.32K +9 New
1
2
3

SER Hedge Fund Activity: Q1 2019 in Review

59 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2019, worth a combined $24.8M — up 32% from $18.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SER positions and 5 closed out — a net gain of 7 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was Price Capital Management, adding an estimated $182K. The largest seller was State of Wisconsin Investment Board, cutting an estimated $429K.

  • 59 institutional investors held Serina Therapeutics (SER) as of Q1 2019, up from 52 in Q4 2018.
  • Funds reported $24.8M of Serina Therapeutics stock for Q1 2019, up 32% quarter-over-quarter.
  • 12 funds opened new Serina Therapeutics positions in Q1 2019 and 5 closed out, a net change of +7 holders.
  • The largest Serina Therapeutics buyer in Q1 2019 was Price Capital Management, an estimated $182K added.
  • The largest Serina Therapeutics seller in Q1 2019 was State of Wisconsin Investment Board, an estimated $429K sold.

Based on aggregated 13F filings for Q1 2019.